169 related articles for article (PubMed ID: 23230284)
1. A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion.
Hulleman JD; Brown SJ; Rosen H; Kelly JW
J Biomol Screen; 2013 Jul; 18(6):647-58. PubMed ID: 23230284
[TBL] [Abstract][Full Text] [Related]
2. Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration.
Hulleman JD; Kelly JW
FASEB J; 2015 Feb; 29(2):565-75. PubMed ID: 25389134
[TBL] [Abstract][Full Text] [Related]
3. Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.
Woodard DR; Nakahara E; Hulleman JD
Sci Rep; 2021 Feb; 11(1):2998. PubMed ID: 33542268
[TBL] [Abstract][Full Text] [Related]
4. Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.
Hulleman JD; Kaushal S; Balch WE; Kelly JW
Mol Biol Cell; 2011 Dec; 22(24):4765-75. PubMed ID: 22031286
[TBL] [Abstract][Full Text] [Related]
5. Translational attenuation differentially alters the fate of disease-associated fibulin proteins.
Hulleman JD; Balch WE; Kelly JW
FASEB J; 2012 Nov; 26(11):4548-60. PubMed ID: 22872678
[TBL] [Abstract][Full Text] [Related]
6. Differential tolerance of 'pseudo-pathogenic' tryptophan residues in calcium-binding EGF domains of short fibulin proteins.
Nguyen A; Hulleman JD
Exp Eye Res; 2015 Jan; 130():66-72. PubMed ID: 25481286
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.
Daniel S; Renwick M; Chau VQ; Datta S; Maddineni P; Zode G; Wade EM; Robertson SP; Petroll WM; Hulleman JD
J Mol Med (Berl); 2020 Nov; 98(11):1639-1656. PubMed ID: 32964303
[TBL] [Abstract][Full Text] [Related]
8. Mapping wild-type and R345W fibulin-3 intracellular interactomes.
Hulleman JD; Genereux JC; Nguyen A
Exp Eye Res; 2016 Dec; 153():165-169. PubMed ID: 27777122
[TBL] [Abstract][Full Text] [Related]
9. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression.
Roybal CN; Marmorstein LY; Vander Jagt DL; Abcouwer SF
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3973-9. PubMed ID: 16249470
[TBL] [Abstract][Full Text] [Related]
10. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.
Fu L; Garland D; Yang Z; Shukla D; Rajendran A; Pearson E; Stone EM; Zhang K; Pierce EA
Hum Mol Genet; 2007 Oct; 16(20):2411-22. PubMed ID: 17666404
[TBL] [Abstract][Full Text] [Related]
11. Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Similarities to Age-Related Macular Degeneration and Potential Therapies.
Hulleman JD
Adv Exp Med Biol; 2016; 854():153-8. PubMed ID: 26427406
[TBL] [Abstract][Full Text] [Related]
12. A Novel Luciferase Assay For Sensitively Monitoring Myocilin Variants in Cell Culture.
Zadoo S; Nguyen A; Zode G; Hulleman JD
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1939-50. PubMed ID: 27092720
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles from retinal pigment epithelial cells expressing R345W-Fibulin-3 induce epithelial-mesenchymal transition in recipient cells.
Zhou M; Zhao Y; Weber SR; Gates C; Carruthers NJ; Chen H; Liu X; Wang HG; Ford M; Swulius MT; Barber AJ; Grillo SL; Sundstrom JM
J Extracell Vesicles; 2023 Oct; 12(10):e12373. PubMed ID: 37855063
[TBL] [Abstract][Full Text] [Related]
14. Expression of R345W-Fibulin-3 Induces Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells.
Zhou M; Weber SR; Zhao Y; Chen H; Barber AJ; Grillo SL; Wills CA; Wang HG; Hulleman JD; Sundstrom JM
Front Cell Dev Biol; 2020; 8():469. PubMed ID: 32637411
[TBL] [Abstract][Full Text] [Related]
15. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction.
Michaelides M; Jenkins SA; Brantley MA; Andrews RM; Waseem N; Luong V; Gregory-Evans K; Bhattacharya SS; Fitzke FW; Webster AR
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3085-97. PubMed ID: 16799055
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations.
Klenotic PA; Munier FL; Marmorstein LY; Anand-Apte B
J Biol Chem; 2004 Jul; 279(29):30469-73. PubMed ID: 15123717
[TBL] [Abstract][Full Text] [Related]
17. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration.
Marmorstein LY; McLaughlin PJ; Peachey NS; Sasaki T; Marmorstein AD
Hum Mol Genet; 2007 Oct; 16(20):2423-32. PubMed ID: 17664227
[TBL] [Abstract][Full Text] [Related]
18. [Development and Application of An Assay for High-throughput Antiviral Compounds Screening against Alphaviruses].
Wei Y; Li J; Wang H; Cen S; Liang G; Tan W; Zhu W
Bing Du Xue Bao; 2015 Nov; 31(6):641-6. PubMed ID: 26951009
[TBL] [Abstract][Full Text] [Related]
19. GSK3 inhibition reduces ECM production and prevents age-related macular degeneration-like pathology.
DiCesare SM; Ortega AJ; Collier GE; Daniel S; Thompson KN; McCoy MK; Posner BA; Hulleman JD
bioRxiv; 2023 Dec; ():. PubMed ID: 38168310
[TBL] [Abstract][Full Text] [Related]
20. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa.
Lotery AJ; Baas D; Ridley C; Jones RP; Klaver CC; Stone E; Nakamura T; Luff A; Griffiths H; Wang T; Bergen AA; Trump D
Hum Mutat; 2006 Jun; 27(6):568-74. PubMed ID: 16652333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
